The role of testosterone in sexuality and paraphilia-a neurobiological approach. Part II: Testosterone and paraphilia

Journal of Sexual Medicine

Volumn 8, Issue 11, 2011, Pages 3008-3029

  Jordan, Kirsten ^a   Fromberger, Peter ^a   Stolpmann, Georg ^a   Müller, Jürgen Leo ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Antiandrogen therapy; Brain; Paraphilia; Sex offenders; Sexuality; Testosterone

Indexed keywords

ADRENALIN; ANDROGEN RECEPTOR; ANTIANDROGEN; CYPROTERONE ACETATE; DOPAMINE; ETHINYLESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; HOMOVANILLIC ACID; LEUPRORELIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; NEUROLEPTIC AGENT; PROLACTIN; PSYCHOSTIMULANT AGENT; SALVACYL; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIPTORELIN; UNCLASSIFIED DRUG;

ADRENALIN BLOOD LEVEL; AMYGDALOID NUCLEUS; ANTIANDROGEN THERAPY; ANTISOCIAL BEHAVIOR; ARCUATE FASCICULUS; BASAL GANGLION; BONE DENSITY; BONE DISEASE; BRAIN DAMAGE; BRAIN SIZE; BREAST CANCER; CAG REPEAT; CEREBELLUM; CINGULATE GYRUS; COGNITIVE THERAPY; CORPUS STRIATUM; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRUG EFFICACY; ENDOMETRIOSIS; ERECTILE DYSFUNCTION; EXHIBITIONISM; EYE TRACKING; FOLLITROPIN BLOOD LEVEL; GYNECOMASTIA; HEART DISEASE; HOT FLUSH; HUMAN; HYPERSEXUALITY; HYPOGONADISM; HYPOPHYSIS GONAD SYSTEM; HYPOTHALAMUS; INFERTILITY; INJECTION SITE REACTION; INSULA; LUTEINIZING HORMONE BLOOD LEVEL; MASTURBATION; META ANALYSIS (TOPIC); NEUROBIOLOGY; NEUROENDOCRINOLOGY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OCCIPITAL CORTEX; ORBITAL CORTEX; PAIN; PARAHIPPOCAMPAL GYRUS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PEDOPHILIA; PERIAQUEDUCTAL GRAY MATTER; PRECUNEUS; PREFRONTAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROSTATE CANCER; PROSTATE CARCINOMA; PSYCHOTHERAPY; REACTION TIME; RECIDIVISM; REVIEW; SEPTUM NUCLEUS; SEXUAL CRIME; SEXUAL DEVIATION; SEXUALITY; SIDE EFFECT; STRIA TERMINALIS; SUBSTANTIA INNOMINATA; SUPERIOR TEMPORAL GYRUS; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL; TURNOVER TIME; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN; WHITE MATTER;

EID: 80053002033     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02393.x     Document Type: Review

References (161)

1. American Psychiatric Association. DSM-IV-TR: Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Publishing; 2000.
2. Blanchard R. The DSM diagnostic criteria for pedophilia. Arch Sex Behav 2010;39:304-16.
3. Hall RCW, Hall RCW. A profile of pedophilia: Definition, characteristics of offenders, recidivism, treatment outcomes, and forensic issues. Mayo Clin Proc 2007;82:457-71.
4. Briken P, Hill A, Berner W. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: A systematic review. J Clin Psychiatry 2003;64:890-7.
5. Lösel F, Schmucker M. The effectiveness of treatment for sexual offenders: A comprehensive meta-analysis. J Exp Criminol 2005;1:117-46.
6. Eher R, Gnoth A, Birklbauer A, Pfäfflin F. Antiandrogene Medikation zur Senkung der Rückfälligkeit von Sexualstraftätern: Ein kritischer Überblick. Recht und Psychiatrie 2007;25:103-11.
7. Guay DRP. Drug treatment of paraphilic and nonparaphilic sexual disorders. Clin Ther 2009;31:1-31.
8. Thibaut F, Barra FDL, Gordon H, Cosyns P, Bradford JMW. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias. World J Biol Psychiatry 2010;11:604-55.
9. Briken P, Kafka MP. Pharmacological treatments for paraphilic patients and sexual offenders. Curr Opin Psychiatry 2007;20:609-13.
10. Jordan K, Fromberger P, Stolpmann G, Müller JL. The role of testosterone in sexuality and paraphilia-A neurobiological approach. Part I: Testosterone and sexuality. J Sex Med 2011. In revision.
11. Mendez MF, Chow T, Ringman J, Twitchell G, Hinkin CH. Pedophilia and temporal lobe disturbances. J Neuropsychiatry Clin Neurosci 2000;12:71-6.
12. Burns JM, Swerdlow RH. Right orbitofrontal tumor with pedophilia symptom and constructional apraxia sign. Arch Neurol 2003;60:437-40.
13. Muller JL. Sadomasochism and hypersexuality in autism linked to amygdalohippocampal lesion? J Sex Med 2009 Sep 14. [Epub ahead of print] doi: 10.1111/j.1743-6109.2009.01485.x.
14. Mendez M, Shapira JS. Pedophilic behavior from brain disease. J Sex Med 2011;8:1092-100.
15. Kaplan MS, Krueger RB. Diagnosis, assessment, and treatment of hypersexuality. J Sex Res 2010;47:181-98.
16. Cannas A, Solla P, Floris GL, Serra G, Tacconi P, Marrosu MG. Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment. J Neurol 2007;254:110-2.
17. Meco G, Rubino A, Caravona N, Valente M. Sexual dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2008;14:451-6.
18. Kafka MP. A monoamine hypothesis for the pathophysiology of paraphilic disorders. Arch Sex Behav 1997;26:343-58.
19. Bradford JM. The neurobiology, neuropharmacology, and pharmacological treatment of the paraphilias and compulsive sexual behaviour. Can J Psychiatry 2001;46:26-34.
20. Kafka MP. The monoamine hypothesis for the pathophysiology of paraphilic disorders: An update. Ann N Y Acad Sci 2003;989:86-94.
21. Schiltz K, Witzel JG, Bogerts B. Hirnstrukturelle Auffälligkeiten bei pädophilen Probanden im Maßregelvollzug. Forensische Psychiatrie und Psychotherapie-Werkstattschriften 2006;13:59-77.
22. Schiltz K, Witzel J, Northoff G, Zierhut K, Gubka U, Fellmann H, Kaufmann J, Tempelmann C, Wiebking C, Bogerts B. Brain pathology in pedophilic offenders: Evidence of volume reduction in the right amygdala and related diencephalic structures. Arch Gen Psychiatry 2007;64:737-46.
23. Schiffer B, Peschel T, Paul T, Gizewski E, Forsting M, Leygraf N, Schedlowski M, Krueger TH. Structural brain abnormalities in the frontostriatal system and cerebellum in pedophilia. J Psychiatr Res 2007;41:753-62.
24. Cantor JM, Kabani N, Christensen BK, Zipursky RB, Barbaree HE, Dickey R, Klassen PE, Mikulis DJ, Kuban ME, Blak T, Richards BA, Hanratty MK, Blanchard R. Cerebral white matter deficiencies in pedophilic men. J Psychiatr Res 2008;42:167-83.
25. Dressing H, Obergriesser T, Tost H, Kaumeier S, Ruf M, Braus DF. Homosexuelle Pädophilie und funktionelle Netzwerke-Eine fMRI-Fallstudie. Fortschr Neurol Psychiatr 2001;69:539-44.
26. Cohen LJ, Nikiforov K, Gans S, Poznansky O, McGeoch P, Weaver C, King EG, Cullen K, Galynker I. Heterosexual male perpetrators of childhood sexual abuse: A preliminary neuropsychiatric model. Psychiatr Q 2002;73:313-36.
27. Wiebking C, Witzel J, Walter M, Gubka U, Northoff G. Vergleich der emotionalen und sexuellen Prozessierung zwischen Gesunden und Patienten mit einer Pädophilie-Eine kombinierte Studie aus Neuropsychologie und fMRT. Forensische Psychiatrie und Psychotherapie-Werkstattschriften 2006;13:79-93.
28. Walter M, Witzel J, Wiebking C, Gubka U, Rotte M, Schiltz K, Bermpohl F, Tempelmann C, Bogerts B, Heinze HJ, Northoff G. Pedophilia is linked to reduced activation in hypothalamus and lateral prefrontal cortex during visual erotic stimulation. Biol Psychiatry 2007;62:698-701.
29. Sartorius A, Ruf M, Kief C, Demirakca T, Bailer J, Ende G, Henn FA, Meyer-Lindenberg A, Dressing H. Abnormal amygdala activation profile in pedophilia. Eur Arch Psychiatry Clin Neurosci 2008;258:271-7.
30. Schiffer B, Paul T, Gizewski E, Forsting M, Leygraf N, Schedlowski M, Kruger THC. Functional brain correlates of heterosexual paedophilia. NeuroImage 2008;41:80-91.
31. Schiffer B, Krueger T, Paul T, de Greiff A, Forsting M, Leygraf N, Schedlowski M, Gizewski E. Brain response to visual sexual stimuli in homosexual pedophiles. J Psychiatry Neurosci 2008;33:23-33.
32. Fromberger P, Krippl M, Stolpmann G, Mueller J. Neurobiologie der pädophilen Störung-Eine methodenkritische Darstellung bisheriger Forschungsergebnisse. Forensische Psychiatrie, Psychologie, Kriminologie 2007;1:249-58.
33. Fromberger P, Stolpmann G, Jordan K, Mueller JL. Neurobiologische Forschung bei Paedophilie-Ergebnisse und deren Konsequenzen fuer die Diagnostik paedosexueller Straftaeter. Zeitschrift fuer Neuropsychologie 2009;20:193-205.
34. Graber B, Hartmann K, Coffman JA, Huey CJ, Golden CJ. Brain damage among mentally disordered sex offenders. J Forensic Sci 1982;27:125-34.
35. Joyal CC, Black DN, Dassylva B. The neuropsychology and neurology of sexual deviance: A review and pilot study. Sex Abuse 2007;19:155-73.
36. Stoleru S, Gregoire MC, Gerard D, Decety J, Lafarge E, Cinotti L, Lavenne F, Le Bars D, Vernet-Maury E, Rada H, Collet C, Mazoyer B, Forest MG, Magnin F, Spira A, Comar D. Neuroanatomical correlates of visually evoked sexual arousal in human males. Arch Sex Behav 1999;28:1-21.
37. Bancroft J, Janssen E. The dual control model of male sexual response: A theoretical approach to centrally mediated erectile dysfunction. Neurosci Biobehav Rev 2000;24:571-9.
38. Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506-33.
39. Krueger RB, Kaplan MS. The paraphilic and hypersexual disorders: An overview. J Psychiatr Pract 2001;7:391-403.
40. Gaffney GR, Berlin FS. Is there hypothalamicpituitarygonadal dysfunction in paedophilia? A pilot study. Br J Psychiatry 1984;145:657-60.
41. Bain J, Langevin R, Hucker S, Dickey R, Wright P, Schonberg C. Sex hormones in pedophiles: I. Baseline values of six hormones II. The gonadotropin releasing hormone test. Sex Abuse 1988;1:443-54.
42. Aromäki AS, Lindman RE, Eriksson CJP. Testosterone, sexuality and antisocial personality in rapists and child molesters: A pilot study. Psychiatry Res 2002;110:239-47.
43. Giotakos O, Markianos M, Vaidakis N, Christodoulou GN. Sex hormones and biogenic amine turnover of sex offenders in relation to their temperament and character dimensions. Psychiatry Res 2004;127:185-93.
44. Maes M, Van West D, De Vos N, Westenberg H, Van Hunsel F, Hendriks D, Cosyns P, Scharpe S. Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia. Neuropsychopharmacology 2001;24:37-46.
45. Krueger T, Schedlowski M, Exton M. Neuroendocrine processes during sexual arousal and orgasm. Janssen E, ed. The psychophysiology of sex. Bloomington, Indianapolis, Indiana University Press; 2007:83-102.
46. Corona G, Mannucci E, Fisher AD, Lotti F, Ricca V, Balercia G, Petrone L, Forti G, Maggi M. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction. J Sex Med 2007;4:1485-93.
47. Corona G, Ricca V, Bandini E, Mannucci E, Lotti F, Boddi V, Rastrelli G, Sforza A, Faravelli C, Forti G, Maggi M. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med 2009;6:1259-69.
48. Holt RIG, Peveler RC. Antipsychotics and hyperprolactinaemia: Mechanisms, consequences and management. Clin Endocrinol (Oxf) 2011;74:141-7.
49. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 1999;19:67-85.
50. Corona G, Mannucci E, Jannini EA, Lotti F, Ricca V, Monami M, Boddi V, Bandini E, Balercia G, Forti G, Maggi M. Hypoprolactinemia: A new clinical syndrome in patients with sexual dysfunction. J Sex Med 2009;6:1457-66.
51. Yatham LN, Steiner M. Neuroendocrine probes of serotonergic function: A critical review. Life Sci 1993;53:447-63.
52. Birger M, Swartz M, Cohen D, Alesh Y, Grishpan C, Kotelr M. Aggression: The testosterone-serotonin link. Isr Med Assoc J 2003;5:653-8.
53. Seo Y, Jeong B, Kim JW, Choi J. Plasma concentration of prolactin, testosterone might be associated with brain response to visual erotic stimuli in healthy heterosexual males. Psychiatry Investig 2009;6:194-203.
54. Aluja A, Garcia LF. Role of sex hormone-binding globulin in the relationship between sex hormones and antisocial and aggressive personality in inmates. Psychiatry Res 2007;152:189-96.
55. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72.
56. Studer LH, Aylwin AS, Reddon JR. Testosterone, sexual offense recidivism, and treatment effect among adult male sex offenders. Sex Abuse 2005;17:171-81.
57. Haake P, Schedlowski M, Exton MS, Giepen C, Hartmann U, Osterheider M, Flesch M, Janssen OE, Leygraf N, Kruger TH. Acute neuroendocrine response to sexual stimulation in sexual offenders. Can J Psychiatry 2003;48:265-71.
58. Dabbs JM, Carr TS, Frady RL, Riad JK. Testosterone, crime, and misbehavior among 692 male prison inmates. Pers Individ Dif 1995;18:627-33.
59. Archer J, Graham-Kevan N, Davies M. Testosterone and aggression: A reanalysis of Book, Starzyk, and Quinsey's (2001) study. Aggress Violent Behav 2005;10:241-61.
60. Bain J, Langevin R, Dickey R, Ben Aron M. Sex hormones in murderers and assaulters. Behav Sci Law 1987;5:95-101.
61. Rada RT, Laws DR, Kellner R. Plasma testosterone levels in the rapist. Psychosom Med 1976;38:257-68.
62. Rada RT, Laws DR, Kellner R, Stivastava L, Peake G. Plasma androgens in violent and nonviolent sex offenders. Bull Am Acad Psychiatry Law 1983;11:149-58.
63. Bradford JM, McLean D. Sexual offenders, violence and testosterone: A clinical study. Can J Psychiatry 1984;29:335-43.
64. Lang RA, Flor-Henry P, Frenzel RR. Sex hormone profiles in pedophilic and incestuous men. Sex Abuse 1990;3:59-74.
65. Gurnani PD, Dwyer M. Serum testosterone levels in sex offenders. J Offender Rehabil 1986;11:39-45.
66. Lang RA, Langevin R, Bain J, Frenzel R, Wright P. Sex hormone profiles in genital exhibitionists. Sex Abuse 1989;2:67-75.
67. Safarinejad MRM. Evaluation of endocrine profile and hypothalamicpituitarytestis axis in selective serotonin reuptake inhibitor-induced male sexual dysfunction. J Clin Psychopharmacol 2008;28:418-23.
68. Maes M, De Vos N, Van Hunsel F, Van West D, Westenberg H, Cosyns P, Neels H. Pedophilia is accompanied by increased plasma concentrations of catecholamines, in particular epinephrine. Psychiatry Res 2001;103:43-9.
69. Westberg L, Eriksson E. Sex steroid-related candidate genes in psychiatric disorders. J Psychiatry Neurosci 2008;33:319-30.
70. Westberg L, Henningsson S, Landen M, Annerbrink K, Melke J, Nilsson S, Rosmond R, Holm G, Anckarsater H, Eriksson E. Influence of androgen receptor repeat polymorphisms on personality traits in men. J Psychiatry Neurosci 2009;34:205-13.
71. Cheng D, Hong CJ, Liao DL, Tsai SJ. Association study of androgen receptor CAG repeat polymorphism and male violent criminal activity. Psychoneuroendocrinology 2006;31:548-52.
72. Rajender S, Pandu G, Sharma J, Gandhi K, Singh L, Thangaraj K. Reduced CAG repeats length in androgen receptor gene is associated with violent criminal behavior. Int J Legal Med 2008;122:367-72.
73. Roney JR, Simmons ZL, Lukaszewski AW. Androgen receptor gene sequence and basal cortisol concentrations predict men's hormonal responses to potential mates. Proc R Soc Lond B Biol Sci 2010;277:57-63.
74. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 1994;22:3181-6.
75. Choong CS, Kemppainen JA, Zhou ZX, Wilson EM. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 1996;10:1527-35.
76. Campbell BC, Gray PB, Eisenberg DT, Ellison P, Sorenson MD. Androgen receptor CAG repeats and body composition among Ariaal men. Int J Androl 2009;32:140-8.
77. Zitzmann M, Nieschlag E. Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 2007;92:3844-53.
78. Manuck SB, Marsland AL, Flory JD, Gorka A, Ferrell RE, Hariri AR. Salivary testosterone and a trinucleotide (CAG) length polymorphism in the androgen receptor gene predict amygdala reactivity in men. Psychoneuroendocrinology 2010;35:94-104.
79. Hebebrand K, Hebebrand J, Remschmidt H. Medikamente in der Behandlung von Paraphilien und hypersexuellen Störungen. Fortschr Neurol Psychiatr 2002;70:462-75.
80. Laschet U, Laschet L. Psychopharmacotherapy of sex offenders with cyproterone acetate. Pharmacopsychiatry 1971;4:99-104.
81. Allolio B, Keffel D, Deuss U, Winkelmann W. Behandlung sexueller Verhaltensstörungen mit LH-RH-Superagonisten. Dtsch Med Wochenschr 1985;110:1952.
82. Schiffer B, Gizewski E, Kruger T. Reduced neuronal responsiveness to visual sexual stimuli in a pedophile treated with a long-acting LH-RH agonist. J Sex Med 2009;6:892-4.
83. Morelli A, Corona G, Filippi S, Ambrosini S, Forti G, Vignozzi L, Maggi M. Which patients with sexual dysfunction are suitable for testosterone replacement therapy? J Endocrinol Invest 2007;30:880-8.
84. Nelson CJ, Lee JS, Gamboa MC, Roth AJ. Cognitive effects of hormone therapy in men with prostate cancer: A review. Cancer 2008;113:1097-106.
85. Leranth C, Prange-Kiel J, Frick KM, Horvath TL. Low CA1 spine synapse density is further reduced by castration in male non-human primates. Cereb Cortex 2004;14:503-10.
86. Cherrier MM, Borghesani PR, Shelton AL, Higano CS. Changes in neuronal activation patterns in response to androgen deprivation therapy: A pilot study. BMC Cancer 2010;10:1.
87. Giltay EJ, Gooren LJG. Potential side effects of androgen deprivation treatment in sex offenders. J Am Acad Psychiatry Law 2009;37:53-8.
88. Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol 2009;181:1998-2008.
89. Rousseau L, Couture M, Dupont A, Labrie F, Couture N. Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism. Can J Psychiatry 1990;35:338-41.
90. Dickey R. The management of a case of treatment-resistant paraphilia with a long-acting LHRH agonist. Can J Psychiatry 1992;37:567-9.
91. Marcus AO, Fernandez MP, De Keyser L. Use of gonadotropin releasing hormone analogue in treatment of exhibitionism [abstract]. Clin Res 1993;1:107.
92. Thibaut F, Cordier B, Kuhn JM. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia. Acta Psychiatr Scand 1993;87:445-50.
93. Cooper AJ, Cernovsky ZZ. Comparison of cyproterone acetate (CPA) and leuprolide acetate (LHRH agonist) in a chronic pedophile: A clinical case study. Biol Psychiatry 1994;36:269-71.
94. Gottesmann H, Yokley J, Sloam D. The use of leuprolide acetate in the treatment of four types of paraphilia. 16th Annual Research and Treatment Conference of the Association for the Treatment of Sexual Abusers October 1997 Arlington, Va 1997.
95. Hansen H, Lykke-Olesen L. Treatment of dangerous sexual offenders in Denmark. J Forens Psychiatry Psychol 1997;8:195-9.
96. Rosler A, Witztum E. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. N Engl J Med 1998;338:416-22.
97. Briken P, Nika E, Berner W. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther 2001;27:45-55.
98. Krueger RB, Kaplan MS. Depot-leuprolide acetate for treatment of paraphilias: A report of twelve cases. Arch Sex Behav 2001;30:409-22.
99. Czerny J-P, Briken P, Berner W. Antihormonal treatment of paraphilic patients in German forensic psychiatric clinics. Eur Psychiatry 2002;17:104-6.
100. Grasswick LJ, Bradford JM. Osteoporosis associated with the treatment of paraphilias: A clinical review of seven case reports. J Forensic Sci 2003;48:849-55.
101. Langevin R, Paitich D, Hucker S, Newman S, Ramsay G, Pope S, Geller G, Anderson C. The effect of assertiveness training, provera and sex of therapist in the treatment of genital exhibitionism. J Behav Ther Exp Psychiatry 1979;10:275-82.
102. McConaghy N, Blaszczynski A, Kidson W. Treatment of sex offenders with imaginal desensitization and/or medroxyprogesterone. Acta Psychiatr Scand 1988;77:199-206.
103. Maletzky BM. The use of Medroxyprogesterone Acetate to assist in the treatment of sexual offenders. Sex Abuse 1991;4:117-29.
104. Fedoroff JP, Wisner-Carlson R, Berlin FS, Dean S. Medroxy-pregesterone acetate in the treatment of paraphilic sexual disorders-Rate of relapse in paraphilic men treated in long-term group psychotherapy with or without medroxy-progesterone acetate. J Offender Rehabil 1992;18:109-24.
105. Meyer WJ III, Cole C, Emory E. Depo provera treatment for sex offending behavior: An evaluation of outcome. Bull Am Acad Psychiatry Law 1992;20:249-59.
106. Maletzky BM, Field G. The biological treatment of dangerous sexual offenders: A review and preliminary report of the Oregon pilot depo-Provera program. Aggress Violent Behav 2003;8:391-412.
107. Sherman L, Gottfredson D, MacKenzie D, Eck J, Reuter P, Bushway S. Preventing crime: What works, what doesn't, what's promising. Report to the U S congress, Washington, DC 1997.
108. Davies TS. Cyproterone acetate in sexual misbehaviour. Med Sci Law 1970;10:237.
109. Murray MA, Anderson DC, Bancroft JH. Proceedings: Sex-hormone-binding globulin, luteinizing hormone and testosterone in man: effects of oestrogen and cyproterone acetate. J Endocrinol 1973;59:xxi-xxii.
110. Brotherton J. Effect of oral cyproterone acetate on urinary and serum FSH and LH levels in adult males being treated for hypersexuality. J Reprod Fertil 1974;36:177-87.
111. Laschet U, Laschet L. Antiandrogens in the treatment of sexual deviations of men. J Steroid Biochem 1975;6:821-6.
112. Cooper AJ. A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Compr Psychiatry 1981;22:458-65.
113. Cooper AJ, Cernovovsky Z. The effect of cyproterone actetate on sleeping and waking penile erections in pedophiles: Possible implications for treatment. Can J Psychiatry 1992;37:33-9.
114. Bradford JM, Pawlak A. Effects of cyproterone acetate on sexual arousal patterns of pedophiles. Arch Sex Behav 1993;22:629-41.
115. Bradford JM, Pawlak A. Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Arch Sex Behav 1993;22:383-402.
116. Money J. The therapeutic use of androgen-depleting hormone. Int Psychiatry Clin 1971;8:165-74.
117. Meyer WJ III, Walker PA, Wiedeking C, Money J, Kowarski AA, Migeon CJ, Borgaonkar DS. Pituitary function in adult males receiving medroxyprogesterone acetate. Fertil Steril 1977;28:1072-6.
118. Gagne P. Treatment of sex offenders with medroxyprogesterone acetate. Am J Psychiatry 1981;138:644-6.
119. Chen JJ, Ladenson PW. Progesterone has no effect on serum thyroxine-binding globulin concentration in men. J Clin Endocrinol Metab 1985;61:983-5.
120. Meyer WJ III, Walker PA, Emory LE, Smith ER. Physical, metabolic, and hormonal effects on men of long-term therapy with medroxyprogesterone acetate. Fertil Steril 1985;43:102-9.
121. Chen JJ, Berlin FS, Margolis S. Effect of large-dose progesterone on plasma levels of lipids, lipoproteins and apolipoproteins in males. J Endocrinol Invest 1986;9:281-5.
122. Kravitz HM, Haywood TW, Kelly J, Liles S, Cavanaugh JL Jr. Medroxyprogesterone and paraphiles: Do testosterone levels matter? Bull Am Acad Psychiatry Law 1996;24:73-83.
123. Thibaut F, Cordier B, Kuhn JM. Gonadotrophin hormone releasing hormone agonist in cases of severe paraphilia: A lifetime treatment? Psychoneuroendocrinology 1996;21:411-9.
124. Schober JM, Kuhn PJ, Kovacs PG, Earle JH, Byrne PM, Fries RA. Leuprolide acetate suppresses pedophilic urges and arousability. Arch Sex Behav 2005;34:691-705.
125. Mothes B, Lehnert J, Samimi F, Ufer J, Raspe G. Klinische Prüfung von cyproteronacetat bei sexualdeviationen. Schering Symposium über sexualdeviationen und ihre medikamentöse Behandlung. Life Science Monographs; 1971.
126. Davies TS. Cyproterone acetate for male hypersexuality. J Int Med Res 1974;2:159-63.
127. Bancroft J, Tennent G, Loucas K, Cass J. The control of deviant sexual behaviour by drugs. I. Behavioural changes following oestrogens and anti-androgens. Br J Psychiatry 1974;125:310-5.
128. Cooper AJ, Sandhu S, Losztyn S, Cernovsky Z. A double-blind placebo controlled trial of medroxyprogesterone acetate and cyproterone acetate with seven pedophiles. Can J Psychiatry 1992;37:687-93.
129. Money J, Bennet BG, Cameron WR. Postadolescent paraphiliac sex offenders: Hormonal and counseling therapy follow-up. Int J Ment Health 1981;6:25-45.
130. Gottesman HG, Schubert DS. Low-dose oral medroxyprogesterone acetate in the management of the paraphilias. J Clin Psychiatry 1993;54:182-8.
131. McConaghy N, Blaszczynski A, Armstrong MS, Kidson W. Resistance to treatment of adolescent sex offenders. Arch Sex Behav 1989;18:97-107.
132. Kravitz HM, Haywood TW, Kelly J, Wahlstrom C, Liles S, Cavanaugh JL Jr. Medroxyprogesterone treatment for paraphiliacs. Bull Am Acad Psychiatry Law 1995;23:19-33.
133. Maletzky BM, Tolan A, McFarland B. The Oregon depo-provera prograxm: A five-year follow-up. Sex Abuse 2006;18:303-16.
134. Wincze JP, Bansal S, Malamud M. Effects of medroxyprogesterone acetate on subjective arousal, arousal to erotic stimulation, and nocturnal penile tumescence in male sex offenders. Arch Sex Behav 1986;15:293-305.
135. Hucker S, Langevin R, Bain J. A double blind trial of sex drive reducing medication in pedophiles. Sex Abuse 1988;1:227-42.
136. Kiersch TA. Treatment of sex offenders with Depo-Provera. Bull Am Acad Psychiatry Law 1990;18:179-87.
137. Saleh FM, Niel T, Fishman MJ. Treatment of paraphilia in young adults with leuprolide acetate: A preliminary case report series. J Forensic Sci 2004;49:1343-8.
138. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957;21:343-9.
139. Thornton D, Laws DR. Cognitive approaches to the assessment of sexual interest in sexual offenders. West Sussex, Oxford, Malden: Wiley-Blackwell; 2009.
140. Snowden RJ, Craig RL, Gray NS. Indirect behavioral measures of cognition among sexual offenders. J Sex Res 2011;48:192-217.
141. Abel GG, Jordan A, Hand CG, Holland LA, Phipps A. Classification models of child molesters utilizing the Abel assessment for sexual interest. Child Abuse Negl 2001;25:703-18.
142. Sachsenmaier SJ, Gress CLZ. The Abel assessment for sexual interests-2: A critical review. Thornton D, Laws DR, eds. Cognitive approaches to the assessment of sexual interest in sexual offenders. Chichester: Wiley-Blackwell; 2009:31-57.
143. Glasgow DV. Affinity: The development of a self-report assessment of paedophile sexual interest incorporating a viewing time validity measure. Thornton D, Laws DR, eds. Cognitive approaches to the assessment of sexual interest in sexual offenders. Chichester: Wiley-Blackwell; 2009:59-84.
144. Glasgow DV, Osborne A, Croxen J. An assessment tool for investigating paedophile sexual interest using viewing time: An application of single case methodology. Br J Learn Disabil 2003;31:96-102.
145. Imhoff R, Schmidt AF, Nordsiek U, Luzar C, Young AW, Banse R. Viewing time effects revisited: Prolonged response latencies for sexually attractive targets under restricted task conditions. Arch Sex Behav 2010;39:1275-88.
146. Gress CLZ, Laws DR. Cognitive modelling of sexual arousal and interest: Choice reaction time measures. Thornton D, Laws DR, eds. Cognitive approaches to the assessment of sexual interest in sexual offenders. Chichester: Wiley-Blackwell; 2009:85-99.
147. Mokros A, Dombert B, Osterheider M, Zappal+á A, Santtila P. Assessment of pedophilic sexual interest with an attentional choice reaction time task. Arch Sex Behav 2010;39:1081-90.
148. Greenwald AG, Poehlman TA, Uhlmann EL, Banaji MR. Understanding and using the Implicit Association Test: III. Meta-analysis of predictive validity. J Pers Soc Psychol 2009;97:17-41.
149. Gray NS, Snowden RJ. The implicit association test as a measure of sexual interest. Thornton D, Laws DR, eds. Cognitive approaches to the assessment of sexual interest in sexual offenders. Chichester: Wiley-Blackwell; 2009:101-23.
150. Fromberger P, Jordan K, Herder JVJ, Steinkrauss H, Nemetschek R, Stolpmann G, Müller JL. Initial orienting towards sexually relevant stimuli: Preliminary evidence from eye movement measures. Arch Sex Behav 2011 [Epub ahead of print] doi: 10.1007/s10508-011-9816-3.
151. Ahlers CJ, Neutze J, Mundt I, Hupp E, Konrad A, Beier KM, Schaefer GA. Erhebungsinstrumente in der klinischen Sexualforschung und der sexualmedizinischen Praxis-Teil II. Sexuologie 2008;15:82-103.
152. Derogatis LR. The derogatis interview for sexual functioning (DISF/DISF-SR): An introductory report. J Sex Marital Ther 1997;23:291-304.
153. Corona G, Ricca V, Bandini E, Mannucci E, Petrone L, Fisher AD, Lotti F, Balercia G, Faravelli C, Forti G, Maggi M. Association between psychiatric symptoms and erectile dysfunction. J Sex Med 2008;5:458-68.
154. Anonymous. Effects of sexual activity on beard growth in man. Nature 1970;226:869-70.
155. Corona G, Ricca V, Boddi V, Bandini E, Lotti F, Fisher AD, Sforza A, Forti G, Mannucci E, Maggi M. Autoeroticism, mental health, and organic disturbances in patients with erectile dysfunction. J Sex Med 2010;7:182-91.
156. Vignozzi L, Corona G, Petrone L, Filippi S, Morelli AM, Forti G, Maggi M. Testosterone and sexual activity. J Endocrinol Invest 2005;28:39-44.
157. Jannini EA, Screponi E, Carosa E, Pepe M, Lo GF, Trimarchi F, Benvenga S. Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone. Int J Androl 1999;22:385-92.
158. Corona G, Mannucci E, Petrone L, Giommi R, Mansani R, Fei L, Forti G, Maggi M. Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction. Int J Impot Res 2004;16:275-81.
159. Bandini E, Corona G, Ricca V, Fisher AD, Lotti F, Sforza A, Faravelli C, Forti G, Mannucci E, Maggi M. Hysterical traits are not from the uterus but from the testis: A study in men with sexual dysfunction. J Sex Med 2009;6:2321-31.
160. Gray PB, Singh AB, Woodhouse LJ, Storer TW, Casaburi R, Dzekov J, Dzekov C, Sinha-Hikim I, Bhasin S. Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. J Clin Endocrinol Metab 2005;90:3838-46.
161. Dreher JC, Meyer-Lindenberg A, Kohn P, Berman KF. Age-related changes in midbrain dopaminergic regulation of the human reward system. Proc Natl Acad Sci USA 2008;105:15106-11.